338 related articles for article (PubMed ID: 10911368)
41. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
42. Folate transport.
Rosenberg IH; Zimmerman J; Selhub J
Chemioterapia; 1985 Oct; 4(5):354-8. PubMed ID: 3907863
[TBL] [Abstract][Full Text] [Related]
43. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
44. Ontogenic regulation of folate transport across rat jejunal brush-border membrane.
Balamurugan K; Said HM
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1068-73. PubMed ID: 12842826
[TBL] [Abstract][Full Text] [Related]
45. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.
Chen ZS; Lee K; Walther S; Raftogianis RB; Kuwano M; Zeng H; Kruh GD
Cancer Res; 2002 Jun; 62(11):3144-50. PubMed ID: 12036927
[TBL] [Abstract][Full Text] [Related]
46. Similar specificity of membrane transport for folate analogues and their metabolites by murine and human tumor cells: a clinically directed laboratory study.
Moccio DM; Sirotnak FM; Samuels LL; Ahmed T; Yagoda A; DeGraw JI; Piper JR
Cancer Res; 1984 Jan; 44(1):352-7. PubMed ID: 6690047
[TBL] [Abstract][Full Text] [Related]
47. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
[TBL] [Abstract][Full Text] [Related]
48. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.
Nakashima-Matsushita N; Homma T; Yu S; Matsuda T; Sunahara N; Nakamura T; Tsukano M; Ratnam M; Matsuyama T
Arthritis Rheum; 1999 Aug; 42(8):1609-16. PubMed ID: 10446858
[TBL] [Abstract][Full Text] [Related]
49. Expression of a folate binding protein in L1210 cells grown in low folate medium.
Jansen G; Kathmann I; Rademaker BC; Braakhuis BJ; Westerhof GR; Rijksen G; Schornagel JH
Cancer Res; 1989 Apr; 49(8):1959-63. PubMed ID: 2702638
[TBL] [Abstract][Full Text] [Related]
50. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
Zhao R; Gao F; Goldman ID
Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
[TBL] [Abstract][Full Text] [Related]
51. Comparison of intestinal folate carrier clone expressed in IEC-6 cells and in Xenopus oocytes.
Kumar CK; Nguyen TT; Gonzales FB; Said HM
Am J Physiol; 1998 Jan; 274(1):C289-94. PubMed ID: 9458739
[TBL] [Abstract][Full Text] [Related]
52. Down-regulation of reduced folate carrier may result in folate malabsorption across intestinal brush border membrane during experimental alcoholism.
Hamid A; Wani NA; Rana S; Vaiphei K; Mahmood A; Kaur J
FEBS J; 2007 Dec; 274(24):6317-28. PubMed ID: 18005257
[TBL] [Abstract][Full Text] [Related]
53. Membrane transport of methotrexate in a squamous carcinoma cell line adapted to low folate concentrations.
van der Laan BF; Jansen G; van Gestel JA; Schornagel JH; Hordijk GJ
Anticancer Res; 1991; 11(3):1265-8. PubMed ID: 1888158
[TBL] [Abstract][Full Text] [Related]
54. Comparison of folic acid uptake characteristics by human placental choriocarcinoma cells at acidic and physiological pH.
Keating E; Lemos C; Azevedo I; Martel F
Can J Physiol Pharmacol; 2006 Feb; 84(2):247-55. PubMed ID: 16900951
[TBL] [Abstract][Full Text] [Related]
55. Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.
Roy K; Chiao JH; Spengler BA; Tolner B; Yang CH; Biedler JL; Sirotnak FM
Cancer Genet Cytogenet; 1998 Aug; 105(1):29-38. PubMed ID: 9689927
[TBL] [Abstract][Full Text] [Related]
56. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
[TBL] [Abstract][Full Text] [Related]
57. Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1).
Hooijberg JH; Jansen G; Assaraf YG; Kathmann I; Pieters R; Laan AC; Veerman AJ; Kaspers GJ; Peters GJ
Biochem Pharmacol; 2004 Apr; 67(8):1541-8. PubMed ID: 15041471
[TBL] [Abstract][Full Text] [Related]
58. RFC-1 gene expression regulates folate absorption in mouse small intestine.
Chiao JH; Roy K; Tolner B; Yang CH; Sirotnak FM
J Biol Chem; 1997 Apr; 272(17):11165-70. PubMed ID: 9111015
[TBL] [Abstract][Full Text] [Related]
59. Increased activity of a novel low pH folate transporter associated with lipophilic antifolate resistance in chinese hamster ovary cells.
Assaraf YG; Babani S; Goldman ID
J Biol Chem; 1998 Apr; 273(14):8106-11. PubMed ID: 9525913
[TBL] [Abstract][Full Text] [Related]
60. Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.
Chung KN; Saikawa Y; Paik TH; Dixon KH; Mulligan T; Cowan KH; Elwood PC
J Clin Invest; 1993 Apr; 91(4):1289-94. PubMed ID: 7682567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
